Vimarsana
Biggest News Aggregation in the World

Page 48 - Randomized Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Clinical Today - Breaking & Trending Today

Both fundoplication surgeries equally effective in improving quality of life of GERD patients - Vimarsana News

Both fundoplication surgeries equally effective in improving quality of life of GERD patients

Sweden: In the long run, partial fundoplication (PF) and complete fundoplication (TF) are equally successful at controlling gastroesophageal Reflux disease (GERD) and improving quality of life, says...

Medically, you might be interested in... - Vimarsana News

Medically, you might be interested in...

A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’, compiled and written by Clare GP Dr Ray O’Connor

Source: imt.ie
Lundbeck to Present New Data at AAN 2022 Adding to Clinical Evidence Regarding VYEPTI - Vimarsana News

Lundbeck to Present New Data at AAN 2022 Adding to Clinical Evidence Regarding VYEPTI

DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 2, 2022--

Source: wsiltv.com
Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes - Vimarsana News

Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes

Ozempic® demonstrated 2.1% blood sugar reduction and also weight loss in adults with type 2 diabetes with new 2 mg dose1PLAINSBORO, N.J., March 28...

Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes - Vimarsana News

Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes

/PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a 2 mg dose of Ozempic® (semaglutide) injection, a...